Jpmorgan Chase & Co »

Cellectar Biosciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $55 20 2.75
2023-09-30 $29 11 2.64

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Cellectar Biosciences

AIGH Capital Management
ADAR1 Capital Management
Nantahala Capital Management
Worth Venture Partners
Rosalind Advisors
Vanguard Group
Citadel Advisors
Raymond James & Associates
Raymond James Financial Services Advisors
LLBH Private Wealth Management
Commerce Bank N A
Simplex Trading
UBS Group
BFSG
Advisor Group Holdings

View all funds holding Cellectar Biosciences